Search
for
Sort by
Research 181–210 of 287
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Interstitial pneumonia with autoimmune features: challenges and controversies
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Safety and efficacy of platelet-rich plasma injection for treatment of erectile dysfunction: a prospective randomized controlled study
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- Innovative Device for Indocianyne Green Navigational Surgery
- Underactive bladder - an underestimated entity
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Resident macrophages of the lung and liver: The guardians of our tissues
- Neutrophil extracellular traps impair regeneration
- The Punctiform Technique in Hair Transplantation
- Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study